glp-1 drugs alzheimer's failed to slow in two big clinical trials Do GLP-1s affect Alzheimer’s biology?

No, not typically

At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits

The results suggest that BPC-157 may have improved functional recovery, as indicated by a potential increase in AFI values at all time points

The steps of the non-oxidative branch of the PPP are reversible and serve to funnel intermediates, such as F6P and G3P, between glycolysis and the PPP

Thank you THANK YOU

Test your levels first so the plan matches the actual cause